These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10751502)

  • 1. Abscess of the lacrimal sac due to chronic or subacute dacryocystitis: treatment with temporary stent placement in the nasolacrimal duct.
    Janssen AG; Mansour K; Bos JJ; Manoliu RA; Castelijns JA
    Radiology; 2000 Apr; 215(1):300-4. PubMed ID: 10751502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.
    Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB
    Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late assessment of internal drainage of chronic dacryocystitis.
    Mansour K; Janssen AG; van Bijsterveld OP
    Ophthalmologica; 2003; 217(1):58-61. PubMed ID: 12566875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dacryolith-induced acute dacryocystitis: a reversible cause of nasolacrimal duct obstruction.
    Dhillon N; Kreis AJ; Madge SN
    Orbit; 2014 Jun; 33(3):199-201. PubMed ID: 24568662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired fistula of the lacrimal sac and laisser-faire approach. Description of the natural history of acquired fistulas between the lacrimal sac and the skin occurring before planned endonasal dacryocystorhinostomy (DCR) and without any treatment of the fistula.
    Pison A; Fau JL; Racy E; Fayet B
    J Fr Ophtalmol; 2016 Oct; 39(8):687-690. PubMed ID: 27587346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal duct obstruction as an important cause of epiphora.
    Avdagic E; Phelps PO
    Dis Mon; 2020 Oct; 66(10):101043. PubMed ID: 32622678
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lacrimal duct obstruction treated with lacrimonasal stent].
    Soler Machín J; Castillo Laguarta JM; De Gregorio Ariza MA; Medrano J; Cristóbal Bescós JA
    Arch Soc Esp Oftalmol; 2003 Jun; 78(6):315-8. PubMed ID: 12838463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results and factors affecting patency after removal of nasolacrimal stents.
    Kim JH; Shin JH; Song HY; Kang W; Lim JO; Park SH; Ko GY; Yoon HK; Sung KB
    J Vasc Interv Radiol; 2006 Jul; 17(7):1125-30. PubMed ID: 16868165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of endonasal intubation of the nasolacrimal duct in children with congenital dacryocystitis].
    Khasanov SA; Babakhanov GK; Zakhidov BA
    Vestn Otorinolaringol; 1991; (5):12-4. PubMed ID: 1755175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of a new nasolacrimal stent].
    Xiao MY; Zhang ZS
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):229-30. PubMed ID: 12536689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conservative treatment of diseases of the tear sac and nasolacrimal canal (a review of the literature)].
    Margolis MG; Bondar' NP
    Voen Med Zh; 1976 Mar; (3):38-41. PubMed ID: 179211
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult nasolacrimal sac mucocele.
    Xiao MY; Tang LS; Zhu H; Li YJ; Li HL; Wu XR
    Ophthalmologica; 2008; 222(1):21-6. PubMed ID: 18097176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile and management outcome of acute dacryocystitis: two decades of experience in a tertiary eye care center.
    Ali MJ; Joshi SD; Naik MN; Honavar SG
    Semin Ophthalmol; 2015 Mar; 30(2):118-23. PubMed ID: 24171807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncocytoma of the lacrimal sac associated with chronic dacryocystitis.
    Chow DR; Brownstein S; Codère F
    Can J Ophthalmol; 1996 Aug; 31(5):249-51. PubMed ID: 8872379
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary vs Secondary Endoscopic Dacryocystorhinostomy for Acute Dacryocystitis With Lacrimal Sac Abscess Formation: A Randomized Clinical Trial.
    Li EY; Wong ES; Wong AC; Yuen HK
    JAMA Ophthalmol; 2017 Dec; 135(12):1361-1366. PubMed ID: 29121183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lacrimal duct stent for nasolacrimal duct obstruction].
    Xiao M; Jiang Y; Zhang Z
    Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):289-91. PubMed ID: 12133376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies of the lacrimal system.
    Kalin-Hajdu E; Cadet N; Boulos PR
    Surv Ophthalmol; 2016; 61(3):309-13. PubMed ID: 26700821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of pediatric dacryocystitis: medical and surgical management of 54 cases.
    Campolattaro BN; Lueder GT; Tychsen L
    J Pediatr Ophthalmol Strabismus; 1997; 34(3):143-53; quiz 186-7. PubMed ID: 9168418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasolacrimal polyurethane stent placement for epiphora: technical long-term results.
    Pabón IP; Díaz LP; Grande C; de la Cal López MA
    J Vasc Interv Radiol; 2001 Jan; 12(1):67-71. PubMed ID: 11200356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacrimal system obstruction treated with lacrimal polyurethane stents: outcome of removal of occluded stents.
    Song HY; Lee DH; Ahn H; Kim JH; Kang SG; Yoon HK; Sung KB
    Radiology; 1998 Sep; 208(3):689-94. PubMed ID: 9722847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.